Olanzapine Combined with 5-HT3 RA Plus Dexamethasone for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting in High and Moderate Emetogenic Chemotherapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Jian-Guo Zhou, Lang Huang, Su-Han Jin, Cheng Xu, Hu Ma
doi: https://doi.org/10.1101/19009456

Article Information

doi 
https://doi.org/10.1101/19009456
History 
  • November 18, 2019.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Jian-Guo Zhou1,*,
  2. Lang Huang2,
  3. Su-Han Jin3,
  4. Cheng Xu2 and
  5. Hu Ma1
  1. 1Department of Oncology, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, China
  2. 2Department of Oncology, GUANGYUAN CENTRAL HOSPITAL, Guangyuan 628000, China
  3. 3Department of Cardiology and Endodontics, Affiliated Stomatological Hospital of Zunyi Medical University, Zunyi 563000, China
  1. ↵*Corresponding author; email: jianguo.zhou{at}yahoo.com

  1. L. H. and J.-G. Z. have contributed equally to this work as first author.

Back to top
Posted November 18, 2019.
Download PDF

Supplementary Material

Data/Code
Email
Olanzapine Combined with 5-HT3 RA Plus Dexamethasone for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting in High and Moderate Emetogenic Chemotherapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Jian-Guo Zhou, Lang Huang, Su-Han Jin, Cheng Xu, Hu Ma
medRxiv 19009456; doi: https://doi.org/10.1101/19009456
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area